NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.570
+0.122 (27.12%)
At close: Feb 21, 2025, 4:00 PM
0.500
-0.070 (-12.20%)
After-hours: Feb 21, 2025, 7:59 PM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $25.60 million as of February 21, 2025. Its market cap has decreased by -24.55% in one year.
Market Cap
25.60M
Enterprise Value
53.61M
1-Year Change
-24.55%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from $338.09M to $25.60M, a decrease of -92.43%. That is a compound annual growth rate of -81.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 25.60M | 8.47% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |